CD276 and renal cell carcinoma: Numerous studies have indicated that the immunomodulatory molecule B7-H3 is significantly upregulated in renal cell carcinoma (RCC), exhibiting the highest expression levels in urothelial and sarcomatoid carcinoma subtypes [69,158,159].